Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria

Annals of Clinical Biochemistry

Volumn 43, Issue 4, 2006, Pages 273-280

  Collinson, Paul O ^a   Gaze, David C ^a   Morris, Francis ^b   Morris, Brian ^b   Price, Alan ^c   Goodacre, Steve ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c DONCASTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; TROPONIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ELECTROCARDIOGRAPHY; EMERGENCY WARD; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHEMISTRY, CLINICAL; CREATINE KINASE, MB FORM; EMERGENCY MEDICINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; TROPONIN T;

EID: 33745930815     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456306777695555     Document Type: Article

References (19)

1. Collinson PO, Rosalki SB, Kuwana T, et al. Early diagnosis of acute myocardial infarction by CK-MB mass measurements. Ann Clin Biochem 1992; 29(Part 1): 43-7
2. Goodacre SW, Morris FM, Campbell S, Arnold J, Angelini K. A prospective, observational study of a chest pain observation unit in a British hospital. Emerg Med J 2002; 19: 117-21
3. Goodacre S, Nicholl J, Dixon S, et al. Randomised controlled trial and economic evaluation of a chest pain observation unit compared with routine care. BMJ 2004; 328: 254-60
4. Newby LK, Storrow AB, Gibler WB, et al. Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Circulation 2001; 103: 1832-7
5. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21: 1502-13
6. Collinson PO, Stubbs PJ, Kessler AC. Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice. Heart 2003; 89: 280-6
7. Collinson PO, Rosalki SB, Flather M, Wolman R, Evans T. Early diagnosis of myocardial infarction by timed sequential enzyme measurements. Ann Clin Biochem 1988; 25(Part 4): 376-82
8. Gibler WB, Young GP, Hedges JR, et al. Acute myocardial infarction in chest pain patients with nondiagnostic ECGs: serial CK-MB sampling in the emergency department. The Emergency Medicine Cardiac Research Group. Ann Emerg Med 1992; 21: 504-12
9. Gibler WB, Lewis LM, Erb RE, et al. Early detection of acute myocardial infarction in patients presenting with chest pain and nondiagnostic ECGs: serial CK-MB sampling in the emergency department [published erratum appears in Ann Emerg Med 1991;20(4):420]. Ann Emerg Med 1990; 19: 1359-66
10. Hedges JR, Young GP, Henkel GF, Gibler WB, Green TR, Swanson JR. Serial ECGs are less accurate than serial CK-MB results for emergency department diagnosis of myocardial infarction. Ann Emerg Med 1992; 21: 1445-50
11. McComb JM, McMaster EA, Jadgey AA. Myoglobin in the very early phase of acute myocardial infarction. Ann Clin Biochem 1985; 22(Part 2): 152-5
12. Lee HS, Cross SJ, Garthwaite P, et al. Comparison of the value of novel rapid measurement of myoglobin, creatine kinase, and creatine kinase-MB with the electrocardiogram for the diagnosis of acute myocardial infarction. Br Heart J 1994; 71: 311-5
13. Kontos MC, Anderson FP, Hanbury CM, Roberts CS, Miller WG, Jesse RL. Use of the combination of myoglobin and CK-MB mass for the rapid diagnosis of acute myocardial infarction. Am J Emerg Med 1997; 15: 14-9
14. Lindahl B, Venge P, Wallentin L. Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemicals markers of acute coronary syndromes. Coron Artery Dis 1995; 6: 321-8
15. James S, Armstrong P, Califf R, et al. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am J Med 2003; 115: 178-84
16. Collinson PO, Moseley D, Stubbs PJ, Carter GD. Troponin T for the differential diagnosis of ischaemic myocardial damage. Ann Clin Biochem 1993; 30(Part 1): 11-6
17. Panteghini M, Apple FS, Christenson RH, Dati F, Mair J, Wu AH. Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes. Scand J Clin Lab Invest Suppl 1999; 230: 103-12
18. Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes Jr R. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999; 45: 1104-21
19. Fesmire FM, Christenson RH, Fody EP, Feintuch TA. Delta creatine kinase-MB outperforms myoglobin at two hours during the emergency department identification and exclusion of troponin positive non-ST-segment elevation acute coronary syndromes. Ann Emerg Med 2004; 44: 12-9